Figure 2.
(A) The effect of oleiferasaponin A2 on HepG2 cells proliferation; (B) the lipid lowering activity of oleiferasaponin A2 under oleic acid treatment; and (C) the content of triglyceride under OA inducement. NC, blank control without oleic acid; 0, model group with 80 μM oleic acid; SVST, group with 80 μM oleic acid and 10 μM simvastain; A2, group with 80 μM oleic acid and 10 μM oleiferasaponin A2. ** p < 0.01, * p < 0.05.